Iovance Biotherapeutics Inc
(IOVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,440 | 17,944 | 19,672 | 130 | 570 |
| Other current assets | 10 | 10 | 0 | 5 | 5 |
| TOTAL | $18,520 | $18,068 | $19,846 | $139 | $579 |
| Non-Current Assets | |||||
| PPE Net | 16 | 15 | 28 | 30 | 19 |
| TOTAL | $16 | $15 | $28 | $30 | $19 |
| Total Assets | $18,535 | $18,083 | $19,874 | $169 | $598 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 441 | 286 | 413 | 1,551 | 1,481 |
| Accrued Expenses | 716 | 823 | 1,857 | 1,958 | 1,888 |
| TOTAL | $1,157 | $1,110 | $2,270 | $3,509 | $3,369 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 167 | 0 | 0 | 0 |
| TOTAL | $N/A | $167 | $N/A | $N/A | $N/A |
| Total Liabilities | $1,157 | $1,277 | $2,270 | $3,509 | $3,369 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 27,226 | 22,437 | 22,059 | 18,893 | 15,094 |
| Common Shares | 246 | 246 | 246 | 646 | 646 |
| Retained earnings | -68,897 | -66,787 | -64,527 | -44,569 | -35,160 |
| TOTAL | $17,379 | $16,806 | $17,604 | $-3,341 | $-2,771 |
| Total Liabilities And Equity | $18,535 | $18,083 | $19,874 | $169 | $598 |